drugset / Trial / NCT07207707
A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies
NaSequentialOpen-labelTreatment
Summary
The goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are: * What is the safe dose of KQB548? * Does KQB548 decrease the size of the tumor? * What happens to KQB548 in the body?
Timeline
- Start
- 2025-09-16
- Primary completion
- 2026-09
- Completion
- 2027-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | KQB548 | Unknown | — | Oral |
Indications
No indication recorded.